Rhodium is an early-stage venture capital firm based in Herzliya, Israel, partnering with passionate founders across AI, social, mobile, and commerce technologies. Founded by Daniel Recanati, the firm invests in pre-seed and seed-stage startups in Israel, New York, and Silicon Valley.
Average disclosed round size is $19.7M (across 5 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Seed
Last 12 Mo
0
Team
AK
Agatha Kratz
Partner
DR
Daniel Recanati
Partner
DR
Daniel Rosen
Partner
JL
John Larsen
Partner
KL
Kate Larsen
Partner
MD
Michael Delgado
Partner
TH
Trevor Houser
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Quamcore | Series A | $26M | Jan 2025 |
 Sharegain | Series B | $64M | Jan 2022 |
 Switch Therapeutics | Seed | $2M | May 2015 |
| FFingerlix | Series C | — | — |
 Verisart | Seed | $2.5M | — |
| HHashable | Unknown | $4M | — |
Top Co-Investors
Group 111 shared
Compound1 shared
BAM Ventures1 shared
WestCap1 shared
Blumberg Capital1 shared
Target Global1 shared
Citi Ventures1 shared
Maverick Ventures Israel1 shared
SixThirty Ventures1 shared
Accel1 shared
Alteria Capital1 shared
Sentinel Global1 shared
Qbeat Ventures1 shared
Viola Ventures1 shared
Fabric Ventures1 shared
Union Square Ventures1 shared
ff Venture Capital1 shared
Last updated: 9 September 2026